swissstaffing - Verband der Personaldienstleister der Schweiz
Actualités sur Study
- Un documentplus
Helsana Drug Report: Spitex patients exposed to significant medication risks
Zurich (ots) - In 2019, medication costs in Switzerland totalled approximately CHF 7.6 billion. The front runners remained cancer and immune system drugs, followed by nervous system medications and metabolic preparations. The use of biosimilars (generic preparations) offers significant savings potential that unfortunately remains almost completely unexploited. In an ...
plusStudy shows dramatic rise in antibiotics prescribed to dental patients in England during COVID-19 lockdown earlier this year
plusDEBIOPHARM LAUNCHES TRILYNX - A LARGE-SCALE PHASE III CLINICAL TRIAL TO FURTHER EVALUATE XEVINAPANT IN THE TREATMENT OF HEAD & NECK CANCER
Lausanne, Switzerland (ots) - First patient dosed in the randomized, placebo-controlled Phase III study of xevinapant (Debio 1143) vs placebo when added to chemoradiotherapy (CRT) in high-risk patients with locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN) Debiopharm (www.debiopharm.com), a ...
plusDEBIOPHARM TO PRESENT LATE BREAKING HEAD & NECK CANCER ABSTRACT AT THE 2020 EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS
Lausanne, Switzerland (ots) - Debiopharm announces the presentation of the 3-year phase II follow-up data along with 2 posters for xevinapant (antagonist of IAP -Inhibitor of Apoptosis Proteins) and WEE1 inhibitor Debio 0123 Debiopharm, ...
Un documentplusswissstaffing - Verband der Personaldienstleister der Schweiz
Flexworkers are the subject of a new study
Un documentplus- 2
FDI World Dental Federation: Global survey shows that less than half (38%) of parents limit their children´s sugary food and drink intake to ensure good oral health
plus swissstaffing - Verband der Personaldienstleister der Schweiz
Swiss Staffingindex - A year under fire: staff leasing sector shrinks by 4.5%
Un documentplusSwissmedic grants approval for pembrolizumab (KEYTRUDA®) in combination with axitinib (Inlyta®) for first-line therapy of advanced renal cell carcinoma(1)
Lucerne (ots) - - Swissmedic approval is based on a significant benefit in overall survival with pembrolizumab in combination with axitinib compared to sunitinib in the Phase III study KEYNOTE-426 - Pembrolizumab is the first PD-1 inhibitor that has ...
Un documentplusHelsana report shows: Medical services on the rise
Zürich (ots) - The "Volume Report" published today by Helsana elucidates the development of medical treatments. In Switzerland, increasing numbers of patients make use of medical treatments. As a result there is an increased need for coordination. General practitioners have less and less time to perform this role. The report finds great potential to meet these coordination needs in other health occupations. In its latest ...
plusAsset Management Study 2019: Sustainable investments and product specialisation as opportunities
Lucerne (ots) - The Institute of Financial Services Zug IFZ, part of Lucerne University of Applied Sciences and Arts, and the Asset Management Platform Switzerland have produced the second edition of the IFZ/AMP Asset Management Study providing a comprehensive overview on asset management in Switzerland. It shows ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Trade agreements only partly shift environmental burden onto poorer countries
Bern (ots) - Is trade liberalisation shifting environmental burden from industrialised countries to poorer ones? This question was investigated by a research team at ETH Zurich led by Thomas Bernauer. In particular, they analysed whether, and if so how, commerce driven by free trade agreements is transferring environmental impacts from industrialised countries to ...
plusswissstaffing - Verband der Personaldienstleister der Schweiz
Permanent Employment for One in Two Temporary Workers
Dübendorf (ots) - Staff leasing is a controversial subject, and everyone seems to have an opinion about it. Two representative surveys conducted by gfs-zürich on behalf of swissstaffing bring new facts to the debate: one in two temporary workers seeking permanent employment were successful within 24 months of beginning their first position. In addition, ...
2 DocumentsplusLucerne School of Business: Who Will Survive the FinTech Evolution?
plusHochschule Luzern: Swiss retail banks with high digitization potential
plusSchweizerischer Nationalfonds / Fonds national suisse
Melting glaciers have a limited impact on Swiss hydropower production
Bern (ots) - A new study quantifies the effect of glacier retreat due to global warming on hydropower production. This detailed analysis of all Swiss water resources shows that only a small percentage is provided by glacier meltwater. Consequently, the reduction of these waters predicted for the end of the 21st century poses no threat to Swiss hydropower production. ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Eating less is healthy thanks to gut bacteria
Bern (ots) - Mice with a lower calorie intake live longer and are both healthier and leaner. A team of researchers funded by the SNSF may have found the reason for this positive effect: much of it is down to gut microbial communities and how they affect the immune system. The researchers also found compounds that mimic caloric restriction and may transform obesity treatments. Reducing the intake of calories by up to 40% ...
plusSequana Medical announces inclusion of alfapump® in EASL Clinical Practice Guidelines and presentation of study demonstrating physical component of QOL is predictor of mortality in refractory ascites
Zurich (ots) - Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of liver disease & malignant ascites, announces two important developments at the recent EASL (European Association for the Study of the Liver) International Liver Congress 2018. First, ...
plusSequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study
Zurich, SWITZERLAND (ots) - Patients with refractory ascites treated with alfapump® system have better health-related quality of life as compared to those treated with large volume paracentesis Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of ...
plusswissstaffing - Verband der Personaldienstleister der Schweiz
Temporary work explained
Un documentplusEnergy efficiency in production - KfW's promotion harnesses potentials / KfW's Energy Efficiency Programme - Production Facilities and Processes has a remarkable impact
Frankfurt am Main (ots) - - Financed enterprises benefit from energy cost savings worth EUR 131 million per year - Annual reduction of 413,000 tonnes of greenhouse gas emissions in Germany - Financed investments secure some 19,000 jobs for a year The energy transition in Germany cannot succeed without significant ...
plusKfW's significant contribution to the energy turnaround: the bank financed 47% of renewable generating capacity installed in Germany in 2015/2016
Frankfurt am Main (ots) - KfW's programmes have a strong impact: - Germany's greenhouse gas emissions down by 9.5 million tonnes each year - EUR 550 million in fuel imports avoided each year - Around 89,000 jobs secured for a year KfW's various domestic programmes for the promotion of renewable energy make a ...
plusShifting gears / New white paper reveals how to succeed in a world of distractions
plusEuropean Society for Medical Oncology (ESMO)
ESMO Publishes New Position Paper on Supportive and Palliative Care
Lugano (ots) - ESMO, the leading professional organisation for medical oncology, published a position paper on supportive and palliative care, calling attention to the evolving and growing gap between the needs of cancer patients and the actual provision of patient-centred care. "New studies show that there may be a gap between what doctors think is important for patients, and what patients really need. With this position ...
plusKfW-Research: Germans see the need for a 'mobility transition' - majority in favour of a speed limit on autobahns
Frankfurt am Main (ots) - - Representative survey: respondents agree change is necessary - High willingness to change personal behaviour also confirmed - One in three respondents has already changed their mobility behaviour - Scepticism towards e-mobility still widespread In the face of increasingly congested roads, ...
plusInmarsat and Deutsche Telekom demonstrate European Aviation Network satellite and ground integration in flight
plusSequana Medical Announces Results of the MOSAIC trial data presented at 2017 AASLD
Zurich (ots) - Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, today announced that Prof. Florence Wong, University of Toronto, presented the findings of the MOSAIC study data at the Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Annual Meeting (The ...
plusSequana Medical Announces 2017 AASLD Poster Presentation
Zurich (ots) - Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, today announced that it will have a poster presentation at the upcoming Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) Annual Meeting (The Liver Meeting®), being held October 20-24 in Washington, DC. Dr. Gijs Klarenbeek,MD, Chief Medical ...
plusKfW-Research: Success factors of high-growth enterprises
Frankfurt am Main (ots) - - Fast-growing enterprises are crucial for economic growth and job creation - Employment of graduates, international orientation and R&D activities are the main drivers of fast growth Successful, fast-growing enterprises are very important for economic development. While the success of enterprises cannot be planned with certainty, high-growth enterprises in Germany have several features that set ...
plusSequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study for the alfapump® vs. Large Volume Paracentesis for Refractory Ascites in Journal of Hepatology
Zurich (ots) - Sequana Medical AG ("Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the publication of a multicentre, randomized controlled trial in the Journal of Hepatology (http://ots.ch/w2er5). The study demonstrated that in patients with ...
plus